Latest News about Phase 3 Trial
Recent news which mentions Phase 3 Trial
BeyondSpring Presents New Plinabulin Data At ESMO Congress
September 16, 2021
Tickers
BYSI
From Benzinga
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
From Benzinga
What's Happening With RedHill Biopharma's Stock On Tuesday?
September 14, 2021
Tickers
RDHL
From Benzinga
Mimedx Stock Plunges After Disappointing Data From Musculoskeletal Trials
September 13, 2021
Tickers
MDXG
From Benzinga
Valneva Shares Plunge As UK Terminates COVID-19 Vaccine Contract: What You Need Know
September 13, 2021
From Benzinga
Apellis Unveils Mixed Results For Eye Disorder Drug, But Still Hopes To Pass FDA Finish Line
September 10, 2021
Tickers
APLS
From Benzinga
AstraZeneca's Imfinzi / Tremelimumab Combo Regime Shows Survival Benefit In Lung Cancer Settings
September 09, 2021
From Benzinga
Sanofi's BTK Inhibitor Disappoints In Phase 3 Autoimmune Disease Trial
September 09, 2021
Tickers
SNY
From Benzinga
AstraZeneca's Two Asthma Trials Meet Primary Endpoints
September 09, 2021
From Benzinga
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
September 08, 2021
From Benzinga
See Why Travere Therapeutics Stock Moving Higher On Tuesday
September 07, 2021
Tickers
TVTX
From Benzinga
Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab
September 07, 2021
From Benzinga
RedHill Unveils New Movantik Data For Opioid-Induced Constipation
September 07, 2021
Tickers
RDHL
From Benzinga
Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients
September 02, 2021
Tickers
PFE
From Benzinga
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
From Benzinga
Merck To Test Oral Antiviral Candidate For Post-Exposure Prophylaxis Of COVID-19 Infection
September 01, 2021
Tickers
MRK
From Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
September 01, 2021
Tickers
TEVA
From Benzinga
From Benzinga
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
August 30, 2021
From Benzinga
Amgen's Repatha Improves Plaque Stability In Heart Patients
August 27, 2021
Tickers
AMGN
From Benzinga
From Benzinga
Edesa Biotech Provides Update For COVID-19 Antibody Trial
August 26, 2021
Tickers
EDSA
From Benzinga
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
August 26, 2021
From Benzinga
Amneal's Parkinson's Candidate Shows Efficacy In Pivotal Trial
August 26, 2021
Tickers
AMRX
From Benzinga
Emergent BioSolutions' COVID-19 Plasma Candidate To Be Tested As Outpatient Treatment
August 25, 2021
Tickers
EBS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
